Starlix (nateglinide), a new oral tablet for type 2 diabetes

You'll see ads for Starlix (nateglinide), a new oral tablet for type 2 diabetes.

Think of it as a shorter-acting Prandin (repaglinide).

Both meds are taken before meals to stimulate insulin release...but Starlix has a shorter duration.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote